Bristol-Myers Squibb Company is a major U.S.-based biopharmaceutical company. It lobbies Congress on health and drug policy, including Medicare and Medicaid rules, patent and other intellectual property protections for medicines, and tax rules that affect the drug industry. Recent filings show it also engages on implementation of the Inflation Reduction Act and global tax and trade issues.
Show the dominant industry call, how mixed the client looks, and the allocation across the top labeled sectors.
Annual totals based on disclosed filing amounts.
Issue rankings are based on disclosed activity mentions, with filing amounts apportioned evenly across issues within the same filing.
The lobbying registrants handling this client, ranked by disclosed filing amounts.
Lobbyists are ranked by appearances and an equal share of each filing's reported amount.
JOHN DEOUDES
The latest disclosures for this client.
BRISTOL-MYERS SQUIBB COMPANY
Q3BRISTOL-MYERS SQUIBB COMPANY
Q2The entities named in disclosed activities are the clearest available signal for where the client is aiming attention.
These contribution items line up to this client through the same lobbying firm and reporting window, and when available the same contributing lobbyist.
BRISTOL-MYERS SQUIBB COMPANY
KATHRYN NOVARIA
BRISTOL-MYERS SQUIBB COMPANY
KIRBY MILLER
BRISTOL-MYERS SQUIBB COMPANY
LANE PENRY
BRISTOL-MYERS SQUIBB COMPANY
SOFIA FOX
BRISTOL-MYERS SQUIBB COMPANY
THOMAS BRUNET
BRISTOL-MYERS SQUIBB COMPANY
RODGER CURRIE
BRISTOL-MYERS SQUIBB COMPANY
MICHAEL CALVO
BRISTOL-MYERS SQUIBB COMPANY
BRISTOL-MYERS SQUIBB COMPANY
Q1BRISTOL-MYERS SQUIBB COMPANY
Q4BRISTOL-MYERS SQUIBB COMPANY
Q3BRISTOL-MYERS SQUIBB COMPANY
Q2BRISTOL-MYERS SQUIBB COMPANY
Q1